IN8BIO, Inc. SEC filings INAB
IN8BIO, Inc. has 410 filings in SEC EDGAR's recent list, going back to May 22, 2018. Its latest annual report, Form ARS, was filed on Mar 26, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 6, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Aug 6, 2026 (results of operations). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 8-K |
Current report
Results of operations
|
Aug 6, 2026 | Aug 6, 2026 |
| 8-K |
Current report
Material agreement, Agreement ended
|
Jun 1, 2026 | May 29, 2026 |
| 8-K |
Current report
Results of operations, Officer or director change, Shareholder vote results
|
May 7, 2026 | May 7, 2026 |
| 8-K |
Current report
Results of operations
|
Mar 12, 2026 | Mar 12, 2026 |
| 8-K |
Current report
Officer or director change
|
Feb 27, 2026 | Feb 26, 2026 |
| 8-K |
Current report
Officer or director change
|
Feb 9, 2026 | Feb 4, 2026 |
| 8-K |
Current report
Material agreement, Unregistered share sale
|
Dec 19, 2025 | Dec 18, 2025 |
| 8-K |
Current report
Other events
|
Nov 24, 2025 | Nov 21, 2025 |
| 8-K |
Current report
Results of operations
|
Nov 6, 2025 | Nov 6, 2025 |
| 8-K |
Current report
Other events
|
Oct 27, 2025 | Oct 27, 2025 |
| 8-K |
Current report
Results of operations
|
Aug 7, 2025 | Aug 7, 2025 |
| 8-K |
Current report
Other events
|
Jun 30, 2025 | Jun 24, 2025 |
| 8-K |
Current report
Change to shareholder rights
|
Jun 4, 2025 | Jun 3, 2025 |
| 8-K |
Current report
Other events
|
Jun 2, 2025 | Jun 2, 2025 |
| 8-K |
Current report
Shareholder vote results
|
May 9, 2025 | May 8, 2025 |
| 8-K |
Current report
Results of operations
|
May 7, 2025 | May 7, 2025 |
| 8-K |
Current report
Other events
|
Apr 28, 2025 | Apr 28, 2025 |
| 8-K |
Current report
Material agreement, Unregistered share sale, Change to shareholder rights
|
Apr 28, 2025 | Apr 27, 2025 |
| 8-K |
Current report
Results of operations
|
Mar 13, 2025 | Mar 13, 2025 |
| 8-K |
Current report
Officer or director change
|
Mar 5, 2025 | Mar 4, 2025 |
| 8-K |
Current report
Other events
|
Mar 3, 2025 | Mar 3, 2025 |
| 8-K |
Current report
Other events
|
Feb 11, 2025 | Feb 11, 2025 |
| 8-K |
Current report
Listing notice
|
Feb 7, 2025 | Feb 5, 2025 |
| 8-K |
Current report
Other events
|
Dec 10, 2024 | Dec 10, 2024 |
| 8-K |
Current report
Other events
|
Nov 25, 2024 | Nov 25, 2024 |
| 8-K |
Current report
Results of operations
|
Nov 12, 2024 | Nov 12, 2024 |
| 8-K |
Current report
Material agreement, Unregistered share sale, Change to shareholder rights
|
Oct 1, 2024 | Sep 30, 2024 |
| 8-K |
Current report
Officer or director change
|
Sep 11, 2024 | Sep 6, 2024 |
| 8-K |
Current report
Officer or director change
|
Sep 6, 2024 | Aug 30, 2024 |
| 8-K |
Current report
Exit or restructuring costs, Other events
|
Sep 4, 2024 | Aug 30, 2024 |
| 8-K |
Current report
Other events
|
Aug 12, 2024 | Aug 12, 2024 |
| 8-K |
Current report
Results of operations
|
Aug 8, 2024 | Aug 8, 2024 |
| 8-K |
Current report
Shareholder vote results, Other events
|
Jun 13, 2024 | Jun 12, 2024 |
| 8-K |
Current report
Other events
|
Jun 3, 2024 | Jun 3, 2024 |
| 8-K |
Current report
Results of operations
|
May 9, 2024 | May 9, 2024 |
| 8-K |
Current report
Results of operations
|
Mar 14, 2024 | Mar 14, 2024 |
| 8-K |
Current report
Material agreement, Unregistered share sale, Regulation FD disclosure
|
Dec 11, 2023 | Dec 11, 2023 |
| 8-K |
Current report
Other events
|
Dec 11, 2023 | Dec 11, 2023 |
| 8-K |
Current report
Officer or director change, Bylaw or fiscal year change
|
Dec 7, 2023 | Dec 6, 2023 |
| 8-K |
Current report
Other events
|
Nov 20, 2023 | Nov 20, 2023 |
| 8-K |
Current report
Results of operations
|
Nov 9, 2023 | Nov 9, 2023 |
| 8-K |
Current report
Other events
|
Oct 12, 2023 | Oct 12, 2023 |
| 8-K |
Current report
Results of operations
|
Aug 10, 2023 | Aug 10, 2023 |
| 8-K |
Current report
Shareholder vote results
|
Jun 16, 2023 | Jun 15, 2023 |
| 8-K |
Current report
Other events
|
Jun 5, 2023 | Jun 5, 2023 |
| 8-K |
Current report
Other events
|
May 17, 2023 | May 17, 2023 |
| 8-K |
Current report
Results of operations
|
May 12, 2023 | May 12, 2023 |
| 8-K |
Current report
Officer or director change
|
May 1, 2023 | May 1, 2023 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Apr 24, 2023 | Apr 24, 2023 |
| 8-K |
Current report
Other events
|
Apr 17, 2023 | Apr 17, 2023 |
| 8-K |
Current report
Results of operations
|
Mar 30, 2023 | Mar 30, 2023 |
| 8-K |
Current report
Regulation FD disclosure
|
Mar 13, 2023 | Mar 10, 2023 |
| 8-K |
Current report
Other events
|
Feb 23, 2023 | Feb 23, 2023 |
| 8-K |
Current report
Other events
|
Jan 5, 2023 | Jan 5, 2023 |
| 8-K |
Current report
Other events
|
Dec 12, 2022 | Dec 12, 2022 |
| 8-K |
Current report
Other events
|
Dec 8, 2022 | Dec 8, 2022 |
| 8-K/A |
Amended current report
Results of operations
|
Dec 6, 2022 | Nov 10, 2022 |
| 8-K |
Current report
Results of operations
|
Nov 10, 2022 | Nov 10, 2022 |
| 8-K |
Current report
Regulation FD disclosure
|
Oct 13, 2022 | Oct 13, 2022 |
| 8-K |
Current report
Regulation FD disclosure
|
Aug 19, 2022 | Aug 19, 2022 |
| 8-K |
Current report
Material agreement, Regulation FD disclosure
|
Aug 16, 2022 | Aug 11, 2022 |
| 8-K |
Current report
Results of operations
|
Aug 12, 2022 | Aug 12, 2022 |
| 8-K |
Current report
Results of operations
|
Aug 8, 2022 | Aug 8, 2022 |
| 8-K |
Current report
Other events
|
Jul 27, 2022 | Jul 27, 2022 |
| 8-K |
Current report
Regulation FD disclosure
|
Jun 8, 2022 | Jun 8, 2022 |
| 8-K |
Current report
Shareholder vote results
|
Jun 2, 2022 | Jun 1, 2022 |
| 8-K |
Current report
Results of operations
|
May 12, 2022 | May 12, 2022 |
| 8-K |
Current report
Other events
|
Mar 28, 2022 | Mar 28, 2022 |
| 8-K |
Current report
Results of operations
|
Mar 17, 2022 | Mar 17, 2022 |
| 8-K |
Current report
Regulation FD disclosure
|
Jan 10, 2022 | Jan 10, 2022 |
| 8-K |
Current report
Other events
|
Dec 16, 2021 | Dec 16, 2021 |
| 8-K |
Current report
Officer or director change
|
Dec 9, 2021 | Dec 1, 2021 |
| 8-K |
Current report
Officer or director change
|
Nov 17, 2021 | Nov 15, 2021 |
| 8-K |
Current report
Results of operations
|
Nov 10, 2021 | Nov 10, 2021 |
| 8-K |
Current report
Results of operations
|
Sep 10, 2021 | Sep 10, 2021 |
| 8-K |
Current report
Bylaw or fiscal year change
|
Aug 3, 2021 | Aug 3, 2021 |
Showing 76 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Biological Products, (No Diagnostic Substances) (SIC 2836)
- Listed as
- INAB (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- New York, NY
- SEC filer status
- Non-accelerated filer, Smaller reporting company, Emerging growth company
- SEC CIK
- 1740279
- Former names
- Incysus Therapeutics, Inc. (until Sep 20, 2018)
Other Biological Products, (No Diagnostic Substances) companies
- Amgen Inc AMGN
- Gilead Sciences, Inc. GILD
- Moderna, Inc. MRNA
- Argenx SE ARGX
- Revolution Medicines, Inc. RVMD
- Biogen Inc. BIIB
- BioNTech SE BNTX
- Exelixis, Inc. EXEL
All 182 Biological Products, (No Diagnostic Substances) companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.